Joshua Blight is a Research Associate and CEO of Baseimmune based in the laboratory of Prof. Jake Baum. He obtained his DPhil at the Jenner Institute at the University of Oxford where he developed computational methods to design vaccine antigens against highly variable pathogens. Two of his vaccines from the University of Oxford are now in clinical trials with one licensed to Vaccitech Ltd from Oxford Innovations.
He previously worked as a Research Associate with a team developing innovate pre-erythrocytic vaccines for malaria. As CEO of Baseimmune he is also working on a number of human and veterinary vaccines.
et al., 2022, Potent virustatic polymer-lipid nanomimics block viral entry and inhibit malaria parasites in vivo, Acs Central Science, Vol:8, ISSN:2374-7943, Pages:1238-1257
et al., 2021, An extracellular redox signal triggers calcium release and impacts the asexual development of Toxoplasma gondii, Frontiers in Cellular and Infection Microbiology, Vol:11, ISSN:2235-2988, Pages:1-14
et al., 2021, Dissection-independent production of a Plasmodium sporozoites from whole mosquitoes, Life Science Alliance, Vol:4, ISSN:2575-1077
et al., 2021, A single-cell atlas of <i>Plasmodium falciparum</i> transmission through the mosquito, Nature Communications, Vol:12
et al., 2021, Detection of Plasmodium falciparum in laboratory-reared and naturally infected wild mosquitoes using near-infrared spectroscopy., Scientific Reports, Vol:11, ISSN:2045-2322, Pages:10289-10289